Granahan Investment Management BIOCRYST PHARMS INC ownership

BIOCRYST PHARMS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 175 filers reported holding BIOCRYST PHARMS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Granahan Investment Management ownership history of BIOCRYST PHARMS INC
ValueSharesWeighting
Q1 2022$7,633
-51.3%
469,430
-58.5%
0.19%
-41.3%
Q4 2021$15,659
+25.6%
1,130,578
+30.3%
0.32%
+35.9%
Q3 2021$12,472
+73.8%
867,920
+91.2%
0.24%
+76.9%
Q2 2021$7,178
+64.2%
453,995
+5.6%
0.13%
+44.1%
Q1 2021$4,372429,9020.09%